0.722

1.77% -0.013

After Hours: .72 -0.002 -0.28%

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $0.722, with a volume of 52,192. It is down -1.77% in the last 24 hours and down -7.44% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$0.735

Open:

$0.72

24h Volume:

52,192

Relative Volume:

0.29

Market Cap:

$23.05M

Revenue:

$7.11M

Net Income/Loss:

$-41.28M

P/E Ratio:

-0.5232

EPS:

-1.38

Net Cash Flow:

$-26.84M

1W Performance:

-7.79%

1M Performance:

-7.44%

6M Performance:

-33.76%

1Y Performance:

-38.29%

1-Day Range:

$0.72

$0.7459

1-Week Range:

$0.72

$0.8399

52-Week Range:

$0.67

$2.2299

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1174)

Industry

Medical Devices (158)

Phone

(801) 278-9769

Address

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Employee

155

Twitter

@Co_Diagnostics

Next Earnings Date

2024-11-07

Latest SEC Filings

CODX's Discussions on Twitter

Compare CODX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CODX Co Diagnostics Inc	0.722	23.05M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	129.10	223.92B	41.95B	13.40B	6.49B	7.65
BSX Boston Scientific Corp	103.54	152.60B	15.91B	1.79B	1.89B	1.21
SYK Stryker Corp	392.39	149.59B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	90.97	116.65B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	71.33	42.07B	6.60B	4.16B	490.10M	6.93

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

Feb 02, 2025

Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Resul - GuruFocus.com

Feb 02, 2025

Jan 30, 2025

Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill - WV News

Jan 30, 2025

Jan 23, 2025

Co-Diagnostics, Inc.: Live from Silicon Slopes - Nasdaq

Jan 23, 2025

Jan 22, 2025

CODX FINAL DEADLINE: ROSEN, A LEADING FIRM, Encourages Co-Diagnostics, Inc. Investors to Contact Firm Before Important August 17 Deadline in Securities Class Action Seeking Recovery of Investor LossesCODX - AccessWire

Jan 22, 2025

Jan 17, 2025

Quest Diagnostics (DGX) Stock Price, News & Analysis - MarketBeat

Jan 17, 2025

Jan 16, 2025

Jane Street Group LLC Makes New $55,000 Investment in Co-Diagnostics, Inc. (NASDAQ:CODX) - Defense World

Jan 16, 2025

Jan 13, 2025

CODX (Co-Diagnostics) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Jan 13, 2025

Jan 10, 2025

Co-Diagnostics faces potential Nasdaq delisting over share price - Investing.com

Jan 10, 2025

Co-Diagnostics faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria

Jan 10, 2025

Jan 07, 2025

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - PR Newswire

Jan 07, 2025

Jan 06, 2025

Head to Head Contrast: Co-Diagnostics (NASDAQ:CODX) vs. Vasamed (OTCMKTS:VSMD) - Defense World

Jan 06, 2025

Dec 30, 2024

Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World

Dec 30, 2024

Dec 24, 2024

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Rele - GuruFocus.com

Dec 24, 2024

Dec 19, 2024

Financial Review: Co-Diagnostics (NASDAQ:CODX) & Endologix (OTCMKTS:ELGXQ) - Defense World

Dec 19, 2024

Dec 16, 2024

Co-Diagnostics stock hits 52-week low at $0.79 amid market challenges - Investing.com

Dec 16, 2024

Dec 13, 2024

CoSara Diagnostics inaugurates new oligo facility in Ranoli, Gujarat - BSI bureau

Dec 13, 2024

Dec 12, 2024

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - Marketscreener.com

Dec 12, 2024

Dec 11, 2024

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - The Eastern Progress Online

Dec 11, 2024

Make in India: CoSara Diagnostics to open oligo facility in Ranoli - Medical Buyer

Dec 11, 2024

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - The Eastern Progress Online

Dec 11, 2024

Dec 06, 2024

Co-Diagnostics stock hits 52-week low at $0.85 amid market challenges - Investing.com Canada

Dec 06, 2024

Dec 05, 2024

Co-Diagnostics (FRA:C97) Earnings Yield % : N/A% (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Co-Diagnostics (FRA:C97) Enterprise Value : €-6.97 Mil (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Co-Diagnostics (STU:C97) Momentum Rank : 7 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Dec 01, 2024

Co-Diagnostics (FRA:C97) EBITDA per Share : €-1.18 (TTM As of Sep. 2024) - GuruFocus.com

Dec 01, 2024

Co-Diagnostics (FRA:C97) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Dec 01, 2024

Co-Diagnostics (HAM:C97) Price-to-Operating-Cash-Flow : (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024

Nov 30, 2024

Co-Diagnostics (HAM:C97) 50-Day SMA : €1.07 (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024

Nov 29, 2024

Rabies Diagnostics Market Report Details Trends and Growth Analysis Report 2024 - WhaTech

Nov 29, 2024

Nov 27, 2024

Co-Diagnostics (HAM:C97) Cash Flow from Operations : €-23.54 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Co-Diagnostics (HAM:C97) Forward Rate of Return (Yacktman) % : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Co-Diagnostics (HAM:C97) Change In Inventory : €0.32 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Co-Diagnostics (HAM:C97) Forward Dividend Yield % : 0.00% (As of Nov. 26, 2024) - GuruFocus.com

Nov 27, 2024

Nov 26, 2024

CODX (Co-Diagnostics) 3-Year Book Growth Rate : 5.60% (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Co-Diagnostics stock hits 52-week low at $1 amid market challenges - Investing.com Australia

Nov 26, 2024

CODX (Co-Diagnostics) Momentum Rank : 8 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 - GuruFocus.com

Nov 26, 2024

Co-Diagnostics stock hits 52-week low at $1 amid market challenges By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 25, 2024

CODX (Co-Diagnostics) 3-Year EPS without NRI Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 24, 2024

Co-Diagnostics (HAM:C97) Cash Flow from Discontinued Operat - GuruFocus.com

Nov 24, 2024

Nov 22, 2024

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results - GuruFocus.com

Nov 22, 2024

Nov 21, 2024

Co-Diagnostics (LTS:0A50) Total Liabilities : $8.60 Mil (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 18, 2024

Daxor (NASDAQ:DXR) & Co-Diagnostics (NASDAQ:CODX) Critical Survey - Defense World

Nov 18, 2024

Nov 14, 2024